Zhejiang Xinhua Chemical Co.,Ltd (SHA:603867)
China · Delayed Price · Currency is CNY 35.78
+0.53 (1.50%)
May 7, 2026, 3:00 PM CST
SHA:603867 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,000 | 2,943 | 2,939 | 2,567 | 2,659 | 2,513 |
Other Revenue | - | - | 26.92 | 29.36 | 24.46 | 42.1 |
| 3,000 | 2,943 | 2,966 | 2,597 | 2,683 | 2,555 | |
Revenue Growth (YoY) | 0.45% | -0.76% | 14.22% | -3.23% | 5.03% | 10.07% |
Cost of Revenue | 2,334 | 2,287 | 2,359 | 1,996 | 2,059 | 2,101 |
Gross Profit | 666.35 | 656.62 | 606.99 | 600.38 | 624.72 | 454.09 |
Selling, General & Admin | 204.14 | 198.92 | 166.25 | 157.83 | 142.9 | 126.16 |
Research & Development | 91.7 | 96.95 | 104.47 | 90.97 | 87.82 | 80.99 |
Other Operating Expenses | -10.68 | -12.71 | 1.9 | 12.7 | 9.98 | 13.12 |
Operating Expenses | 285.16 | 283.16 | 283.05 | 263.16 | 242.48 | 221.42 |
Operating Income | 381.19 | 373.46 | 323.93 | 337.22 | 382.24 | 232.67 |
Interest Expense | - | - | -24.82 | -25.61 | -9.17 | -8.03 |
Interest & Investment Income | 1.26 | - | 6.08 | 12.72 | 13.98 | 11.77 |
Currency Exchange Gain (Loss) | - | - | 11.3 | 4.55 | 14.48 | -3.28 |
Other Non Operating Income (Expenses) | -41.13 | -42.98 | -1.4 | -0.53 | -0.87 | -0.92 |
EBT Excluding Unusual Items | 341.31 | 330.48 | 315.09 | 328.35 | 400.66 | 232.21 |
Gain (Loss) on Sale of Investments | 0.2 | -0.53 | -2.71 | - | - | - |
Gain (Loss) on Sale of Assets | 33.24 | 32.66 | -0.62 | -1.65 | -3.15 | 1.57 |
Asset Writedown | -1.95 | -1.95 | - | - | - | - |
Other Unusual Items | - | - | 7.42 | 11.02 | 19.44 | 8.33 |
Pretax Income | 372.8 | 360.66 | 319.17 | 337.72 | 416.95 | 242.1 |
Income Tax Expense | 61.41 | 58.22 | 44.29 | 48.95 | 47.35 | 31.85 |
Earnings From Continuing Operations | 311.39 | 302.45 | 274.88 | 288.78 | 369.61 | 210.25 |
Minority Interest in Earnings | -41.25 | -42.01 | -47.96 | -36.16 | -40.38 | -13.44 |
Net Income | 270.14 | 260.44 | 226.91 | 252.62 | 329.23 | 196.82 |
Net Income to Common | 270.14 | 260.44 | 226.91 | 252.62 | 329.23 | 196.82 |
Net Income Growth | 21.49% | 14.77% | -10.18% | -23.27% | 67.27% | -4.25% |
Shares Outstanding (Basic) | 197 | 189 | 183 | 186 | 184 | 182 |
Shares Outstanding (Diluted) | 197 | 189 | 194 | 190 | 185 | 182 |
Shares Change (YoY) | -0.47% | -2.69% | 2.11% | 2.69% | 1.49% | 0.26% |
EPS (Basic) | 1.37 | 1.38 | 1.24 | 1.36 | 1.79 | 1.08 |
EPS (Diluted) | 1.37 | 1.38 | 1.17 | 1.33 | 1.78 | 1.08 |
EPS Growth | 22.07% | 17.95% | -12.03% | -25.28% | 64.81% | -4.49% |
Free Cash Flow | 22.7 | -20.5 | 86.59 | -102.6 | -197.11 | -206.41 |
Free Cash Flow Per Share | 0.12 | -0.11 | 0.45 | -0.54 | -1.07 | -1.13 |
Dividend Per Share | - | - | 0.450 | 0.450 | 0.550 | 0.385 |
Dividend Growth | - | - | - | -18.18% | 43.01% | 11.09% |
Gross Margin | 22.21% | 22.31% | 20.47% | 23.12% | 23.28% | 17.77% |
Operating Margin | 12.71% | 12.69% | 10.92% | 12.99% | 14.24% | 9.11% |
Profit Margin | 9.00% | 8.85% | 7.65% | 9.73% | 12.27% | 7.70% |
Free Cash Flow Margin | 0.76% | -0.70% | 2.92% | -3.95% | -7.35% | -8.08% |
EBITDA | 560.55 | 542.73 | 452.84 | 436.76 | 479.45 | 317.83 |
EBITDA Margin | 18.68% | 18.44% | 15.27% | 16.82% | 17.87% | 12.44% |
D&A For EBITDA | 179.37 | 169.27 | 128.91 | 99.53 | 97.2 | 85.16 |
EBIT | 381.19 | 373.46 | 323.93 | 337.22 | 382.24 | 232.67 |
EBIT Margin | 12.71% | 12.69% | 10.92% | 12.99% | 14.24% | 9.11% |
Effective Tax Rate | 16.47% | 16.14% | 13.88% | 14.49% | 11.36% | 13.15% |
Revenue as Reported | - | - | 2,966 | 2,597 | 2,683 | 2,555 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.